Lantheus Holdings Inc logo

Lantheus Holdings Inc

LNTH
Healthcare|Drug Manufacturers - Specialty & Generic|USA
$105.64
-0.34 (-0.32%)
DCF (FCF)
$69.11
Tangible Book
$4.10
Graham Number
$22.41
Earnings Power
$25.99

Analyst Estimates

annual
{ "date": [ "202612", "202712", "202812", "202912", "203012" ], "revenue_estimate": [ 1463.48, 1652.43, 1867.74, 2053.44, 2202.47 ], "ebit_estimate": [ 477.13, 540.83, 652.63, 730.63, 780.83 ], "ebitda_estimate": [ 516.93, 600.97, 703.6, 786.94, null ], "net_income_estimate": [ 356.57, 433.69, 500.54, 523.93, 533.7 ], "per_share_eps_estimate": [ 4.47, 5.49, 7.27, 6.32, null ], "eps_nri_estimate": [ 5.3, 6.37, 7.59, 8.01, 8.6 ], "dividend_estimate": [ null, null, null, null, null ], "book_value_per_share_estimate": [ null, null, null, null, null ], "pretax_income_estimate": [ 469.33, 545.58, 667.39, 760.06, 918 ], "operating_cash_flow_per_share_estimate": [ null, null, null, null, null ], "roa_estimate": [ null, null, null, null, null ], "roe_estimate": [ 20.49, 20.47, 20.17, 19.09, null ], "gross_margin_estimate": [ 64.75, 65.89, 66.88, 65.8, 68 ], "operating_cash_flow_estimate": [ null, null, null, null, null ], "pettm_estimate": [ 23.64, 19.24, 14.54, 16.7, null ], "long_term_growth_rate_mean": 8.86, "long_term_revenue_growth_rate_mean": "7.22", "future_per_share_eps_estimate_growth": 28.08, "future_eps_nri_estimate_growth": 8.86, "future_revenue_estimate_growth": 7.22, "future_ebit_estimate_growth": null, "future_ebitda_estimate_growth": 19.93, "future_dividend_estimate_growth": null, "future_net_income_estimate_growth": 7.76, "future_pretax_income_estimate_growth": 27.31, "future_book_value_per_share_estimate_growth": null, "future_roa_estimate_growth": null, "future_roe_estimate_growth": -15.53, "future_gross_margin_estimate_growth": 2.93, "future_operating_cash_flow_per_share_estimate_growth": null }
quarterly
{ "date": [ "202606", "202609", "202612", "202703", "202706", "202709", "202712", "202803" ], "revenue_estimate": [ 362.04, 360.81, 371.19, 387.03, 395.74, 408.76, 428.25, 437.41 ], "ebit_estimate": [ 117.33, 117.6, 123.6, 113.81, 125.4, 139, 157.9, null ], "ebitda_estimate": [ 122.88, 124.23, 116.9, 158.48, null, null, null, null ], "net_income_estimate": [ 85.35, 85.4, 91.36, 104.09, 114.25, 122.36, 135.22, null ], "per_share_eps_estimate": [ 0.99, 1.01, 1.14, 1.44, 1.56, 1.62, 1.7, null ], "eps_nri_estimate": [ 1.3, 1.29, 1.36, 1.41, 1.49, 1.55, 1.88, 1.55 ], "dividend_estimate": [ null, null, null, null, null, null, null, null ], "book_value_per_share_estimate": [ null, null, null, null, null, null, null, null ], "pretax_income_estimate": [ 114.17, 114.33, 122.21, 115.8, 125.9, 139.5, 158.3, null ], "operating_cash_flow_per_share_estimate": [ null, null, null, null, null, null, null, null ], "roa_estimate": [ null, null, null, null, null, null, null, null ], "roe_estimate": [ null, null, null, null, null, null, null, null ], "gross_margin_estimate": [ 65.05, 64.75, 64.86, 66, 66, 66, 66, null ], "operating_cash_flow_estimate": [ null, null, null, null, null, null, null, null ], "pettm_estimate": [ 23.14, 20.55, 18.36, 16.72, null, null, null, null ], "long_term_growth_rate_mean": 8.86, "long_term_revenue_growth_rate_mean": "7.22", "future_per_share_eps_estimate_growth": 28.08, "future_eps_nri_estimate_growth": 8.86, "future_revenue_estimate_growth": 7.22, "future_ebit_estimate_growth": null, "future_ebitda_estimate_growth": 19.93, "future_dividend_estimate_growth": null, "future_net_income_estimate_growth": 7.76, "future_pretax_income_estimate_growth": 27.31, "future_book_value_per_share_estimate_growth": null, "future_roa_estimate_growth": null, "future_roe_estimate_growth": -15.53, "future_gross_margin_estimate_growth": 2.93, "future_operating_cash_flow_per_share_estimate_growth": null }

News

2026-07-09 14:42:16
2026-07-09 00:28:43
2026-07-06 23:23:48
2026-06-29 13:35:11
2026-06-26 22:56:05
2026-06-26 20:27:21
2026-06-25 23:06:15